Halberd’s Patented LDN+ Drug Has Begun Pre-Pilot Trials With Military Veterans

2 years ago

LDN+ Drug Designed to Combat PTSD and Suicidal IdeationJACKSON CENTER, PA / ACCESSWIRE / April 30, 2024 / Halberd Corporation…

Ovation Science Topicals Launch with Planet 13 in Nevada

2 years ago

VANCOUVER, BC and LAS VEGAS, NV / ACCESSWIRE / April 30, 2024 / Ovation Science Inc. ("Ovation" or the "Company")…

Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET

2 years ago

ANN ARBOR, MI / ACCESSWIRE / April 30, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary…

Planet 13 Launches New MEDIZIN Branded Topicals – Introducing MEDIZIN Rest, Recovery and Relief

2 years ago

LAS VEGAS, NV / ACCESSWIRE / April 30, 2024 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNH) ("Planet 13" or the "Company"),…

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon

2 years ago

SHELTON, CT / ACCESSWIRE / April 30, 2024 / NanoViricides, Inc. (NYSE Amer:NNVC) (the "Company"), a global leader in broad-spectrum…

MindBio Therapeutics Announces Landmark Women’s Health CNS Drug Trials

2 years ago

ASSESSING THE EFECTS OF MICRODOSING MB22001 IN MENSTRUATING PERSONS WITH AND WITHOUT PREMENSTRUAL SYNDROME AND PREMENSTRUAL DYSPHORIC DISORDER Multiple clinical trials…

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia

2 years ago

Cannabix is developing alcohol and marijuana breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER,…

Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting

2 years ago

At DDG, Fractyl Health will present new clinical updates on its ongoing real-world registry study of Revita® in patients with…

Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)

2 years ago

Proof-of-mechanism data for WVE-006 in individuals with AATD remain on track for 2024CAMBRIDGE, Mass., April 30, 2024 (GLOBE NEWSWIRE) --…